Literature DB >> 2539706

Multiplicity dependent expression of the predominant phosphoprotein pp65 of human cytomegalovirus.

S Klages1, B Rüger, G Jahn.   

Abstract

Recent clinical isolates of human cytomegalovirus (HCMV) display considerable quantitative differences in the expression of the structural phosphoprotein pp65. This study shows that a reduced production of pp65 correlates with reduced amounts of its coding transcript in wild-type strains compared to the high level expression in the laboratory strain AD169. The cleavage pattern of the encoding DNAs including the promoter region did not show major differences among the isolates. Therefore the variable expression of pp65 is supposed to be dependent on cell culture conditions. Increasing multiplicities of infection resulted in overproduction of pp65 and this may lead to the increased formation of dense body particles.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539706     DOI: 10.1016/0168-1702(89)90061-0

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  11 in total

1.  Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).

Authors:  R Holtappels; J Podlech; N K Grzimek; D Thomas; M F Pahl-Seibert; M J Reddehase
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication.

Authors:  Veronica Sanchez; Charles L Clark; Judy Y Yen; Roopashree Dwarakanath; Deborah H Spector
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Large-scale screening of human sera with cytomegalovirus recombinant antigens.

Authors:  M P Landini; M X Guan; G Jahn; W Lindenmaier; M Mach; A Ripalti; A Necker; T Lazzarotto; B Plachter
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Proteins associated with purified human cytomegalovirus particles.

Authors:  C J Baldick; T Shenk
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  The proteome of human cytomegalovirus virions and dense bodies is conserved across different strains.

Authors:  Nicole Büscher; Christina Paulus; Michael Nevels; Stefan Tenzer; Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2015-03-03       Impact factor: 3.402

6.  Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses.

Authors:  B Plachter; S Klages; S Hagelmann; W Britt; M P Landini; G Jahn
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Strain-specific neutralization of human cytomegalovirus isolates by human sera.

Authors:  M Klein; K Schoppel; N Amvrossiadis; M Mach
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection.

Authors:  Min Hua Luo; Philip H Schwartz; Elizabeth A Fortunato
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150.

Authors:  B Plachter; L Wieczorek; B C Scholl; R Ziegelmaier; G Jahn
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly.

Authors:  Heidi Theeten; Catharina Mathei; Kelly Peeters; Benson Ogunjimi; Herman Goossens; Margareta Ieven; Pierre Van Damme; Nathalie Cools
Journal:  Viral Immunol       Date:  2016-03-22       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.